Optimizing Anticoagulation Management in Atrial Fibrillation: Beyond the Guidelines. How and for Whom?

J Cardiovasc Pharmacol. 2023 Jun 1;81(6):395-396. doi: 10.1097/FJC.0000000000001423.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anticoagulants / adverse effects
  • Atrial Fibrillation* / diagnosis
  • Atrial Fibrillation* / drug therapy
  • Blood Coagulation
  • Humans
  • Risk Factors
  • Stroke* / diagnosis
  • Stroke* / etiology
  • Stroke* / prevention & control

Substances

  • Anticoagulants